☆ 4.8 Editorial Material

Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo: A new potential therapeutic modality

HEPATOLOGY (2018)

Get Full Text
Add to Collection

Journal

HEPATOLOGY
Volume 68, Issue 3, Pages 1191-1193

Publisher

WILEY
DOI: 10.1002/hep.29860

Keywords

-

Categories

Gastroenterology & Hepatology

Funding

  1. NIH [DK111397, R01 DK110024]
  2. North American Society of Pediatric Gastroenterology Hepatology and Nutrition Young Investigator Award/Nestle Nutrition Award
  3. Gilead Sciences
  4. Mayo Clinic

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.